Arcutis Biotherapeutics Inc. (ARQT): Price and Financial Metrics
ARQT Price/Volume Stats
| Current price | $8.47 | 52-week high | $15.21 |
| Prev. close | $8.59 | 52-week low | $1.76 |
| Day low | $8.36 | Volume | 2,163,560 |
| Day high | $8.85 | Avg. volume | 4,597,418 |
| 50-day MA | $10.12 | Dividend yield | N/A |
| 200-day MA | $6.50 | Market Cap | 820.01M |
ARQT Stock Price Chart Interactive Chart >
Arcutis Biotherapeutics Inc. (ARQT) Company Bio
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
Latest ARQT News From Around the Web
Below are the latest news stories about ARCUTIS BIOTHERAPEUTICS INC that investors may wish to consider to help them evaluate ARQT as an investment opportunity.
The Zacks Analyst Blog Highlights Allogene Therapeutics, Arcutis Biotherapeutics and C4 TherapeuticsAllogene Therapeutics, Arcutis Biotherapeutics and C4 Therapeutics are part of the Zacks top Analyst Blog. |
3 Under-$10 Drug Stocks Wall Street Analysts Recommend BuyingWe present three small biotech stocks, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2024 following signals of a stabilizing market. |
11 High Growth Micro-Cap Stocks to BuyIn this article, we discuss 11 high-growth micro-cap stocks to buy. To skip the detailed analysis and past performance of micro-cap stocks, go directly to the 5 High Growth Micro-cap Stocks to Buy. Shares of small companies with market capitalization usually between $50 to $300 million are considered micro-cap stocks. The risk in these investments […] |
Arcutis (ARQT) Up on FDA Nod for Zoryve in Seborrheic DermatitisThe FDA approves Arcutis' (ARQT) NDA for Zoryve topical foam 0.3% for treating seborrheic dermatitis in individuals nine years of age and above. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning! |
ARQT Price Returns
| 1-mo | -11.68% |
| 3-mo | 59.81% |
| 6-mo | 262.74% |
| 1-year | -38.44% |
| 3-year | -72.07% |
| 5-year | N/A |
| YTD | 162.23% |
| 2023 | -78.18% |
| 2022 | -28.64% |
| 2021 | -26.27% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...